Literature DB >> 8954952

An anti-HIV peptide, T22, forms a highly active complex with Zn(II).

H Tamamura1, A Otaka, T Murakami, T Ibuka, K Sakano, M Waki, A Matsumoto, N Yamamoto, N Fujii.   

Abstract

T22 ([Tyr5,12, Lys7]-polyphemusin II) has been shown to have strong anti-human immunodeficiency virus (HIV) activity, comparable to that of 3'-azide-2', 3'-dideoxythymidine (AZT). T22 takes an antiparallel beta-sheet structure maintained by two disulfide bridges and contains two antiparallel repeats of Cys-Tyr-Arg-Lys-Cys. As reported herein, fully reduced T22 was found by HPLC and ion spray mass spectrometric analyses to form a complex in a molar ratio of 1:1 with Zn(II) ion at neutral pH in aqueous solution. Complexation of Zn(II) ion to this peptide appears to result in tetracoordinate bonding to sulfur atoms of four Cys residues. We also found that the anti-HIV activity of the T22-Zn(II) complex was fourfold stronger than that of T22.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954952     DOI: 10.1006/bbrc.1996.1858

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure.

Authors:  R Arakaki; H Tamamura; M Premanathan; K Kanbara; S Ramanan; K Mochizuki; M Baba; N Fujii; H Nakashima
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

2.  Synthesis of protein kinase Cdelta C1b domain by native chemical ligation methodology and characterization of its folding and ligand binding.

Authors:  Nami Ohashi; Wataru Nomura; Mai Kato; Tetsuo Narumi; Nancy E Lewin; Peter M Blumberg; Hirokazu Tamamura
Journal:  J Pept Sci       Date:  2009-10       Impact factor: 1.905

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.